Management of ITP

Weill Cornell Medicine Oncology & Hematology
Avatar

SYK Inhibitors for the Treatment of ITP

By Weill Cornell Medicine Oncology & Hematology FEATURING James Bussel
By Weill Cornell Medicine Oncology & Hematology FEATURING James Bussel
180 views
April 6, 2022
Comments 0
Login to view comments. Click here to Login
17:31

Fostamatinib in the Treatment of Chronic ITP

Aron Kefela

334 views
15:32

Second Line Therapy for ITP

Amy Zhou

363 views
14:24

Venous Thromboembolism and Immune Thrombocytopenia

Cindy Neunert

208 views
33:05

UC Denver ASH Review: Updates on Benign Hematology

University of Colorado Division of Hematology

A. Metjian

149 views
14:00

Hematologic irAEs (VTEs)

Cleveland Clinic's 2022 Management of Checkpoint Inhibitor-Related Toxicities

K. McCrae

117 views
19:13

ASH 2021 Highlights on Thrombosis and Anticoagulation

Yale Cancer Center

A. Pine

164 views
19:36

Managing Hematologic Toxicities From Immunotherapeutic Agents

Moffitt Cancer Center's 17th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

M. Jaglal

295 views
41:39

Venous Thromboembolism in Lymphoma: Risk Stratification, Prophylaxis…

19th Annual International Ultmann Chicago Lymphoma Symposium

K. Cohen

152 views
21:51

Thrombotic Microangiopathies: Modern Diagnosis and Treatments

Rush University Medical Center

S. Cataland

88 views
31:21

Benign Hematology: Clotting, Bleeding, and More

Indy Hematology Review

C. Kessler

55 views